C12N 9/647
Blood coagulation factors not provided for in a preceding group or according
Official title: {Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups}
C12N9/647 (Blood coagulation factors not provided for in a preceding group or according) appears on 163 US grants and 148 published applications in this corpus.
Search patents in C12N- Granted patents
- 163
- Published applications
- 148
- Assignees
- 97
- Inventors
- 256
- Latest grant
- 21 Jan 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 2 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 3 | 0 |
| 1983 | 4 | 0 |
| 1984 | 2 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 4 | 0 |
| 1989 | 2 | 0 |
| 1990 | 4 | 0 |
| 1991 | 2 | 0 |
| 1992 | 6 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 4 | 0 |
| 1996 | 3 | 0 |
| 1997 | 6 | 0 |
| 1998 | 4 | 0 |
| 1999 | 5 | 0 |
| 2000 | 6 | 0 |
| 2001 | 3 | 1 |
| 2002 | 2 | 5 |
| 2003 | 2 | 10 |
| 2004 | 6 | 5 |
| 2005 | 1 | 10 |
| 2006 | 4 | 12 |
| 2007 | 4 | 10 |
| 2008 | 7 | 10 |
| 2009 | 6 | 12 |
| 2010 | 10 | 8 |
| 2011 | 6 | 10 |
| 2012 | 6 | 5 |
| 2013 | 3 | 9 |
| 2014 | 7 | 6 |
| 2015 | 4 | 3 |
| 2016 | 7 | 4 |
| 2017 | 4 | 4 |
| 2018 | 5 | 2 |
| 2019 | 2 | 4 |
| 2020 | 1 | 2 |
| 2021 | 4 | 4 |
| 2022 | 3 | 1 |
| 2023 | 1 | 6 |
| 2024 | 1 | 2 |
| 2025 | 1 | 3 |
By publication year. Applications have been published since 2001.
Recent patents
- Pipette tip and uses and methods thereof21 Jan 2025US 12,201,973 B2enicor GmbH
- Gene editing for hemophilia A with improved factor VIII expression25 Jun 2024US 12,016,932 B2Bayer HealthCare LLC
- Pipette tip and uses and methods thereof17 Jan 2023US 11,554,368 B2
- Gene editing for hemophilia A with improved factor VIII expression20 Dec 2022US 11,529,427 B2Bayer HealthCare LLC
- Factor B and C2 protein point mutants, a method for enhancing the activity of anti-cancer antibodies, the pharmaceutical composition and the use of mutants16 Aug 2022US 11,414,468 B2Gdanski Uniwersytet Medyczny
- Method of producing biologically active vitamin k dependent proteins by recombinant methods21 Aug 2025US 2025/0263769 A1Aptevo Biotherapeutics LLC
- Recombinant vitamin k dependent proteins with high sialic acid content and methods of preparing same17 Jul 2025US 2025/0230426 A1Aptevo Biotherapeutics LLC
- Pipette tip and uses and methods thereof27 Feb 2025US 2025/0065321 A1enicor GmbH
- Gene editing for hemophilia a with improved factor viii expression19 Dec 2024US 2024/0415981 A1Bayer HealthCare LLC
- An antibody, a pharmaceutical composition, and a method21 Mar 2024US 2024/0092889 A1
Most cited
By later US patents
- Immunoglobulin chimeric monomer-dimer hybrids215US 7,404,956 B2Syntonix Pharmaceuticals, Inc. · 2008
- Expression of factor VII activity in mammalian cells201US 4,784,950 AZymoGenetics, Inc. · 1988
- Conjugates of a polypeptide and a biocompatible polymer198US 6,048,720 APharmacia & Upjohn Company · 2000
- Immunoglobulin chimeric monomer-dimer hybrids165US 7,348,004 B2Syntonix Pharmaceuticals, Inc. · 2008
- Modified factor VIII132US 4,970,300 ANew York University · 1990